Screening compound: InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H

Screening compound: InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H
Screening compound: InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K505-0559

Molecular Formula

C22H15FN2O2 (C22 H15 FN2 O2)

Compound Name

2-[(1Z)-2-(2-fluorophenyl)ethenyl]-3-(4-hydroxyphenyl)-3,4-dihydroquinazolin-4-one

IUPAC name

2-[(1Z)-2-(2-fluorophenyl)ethenyl]-3-(4-hydroxyphenyl)-34-dihydroquinazolin-4-one

SMILES

Oc(cc1)ccc1N(C(/C=C\c(cccc1)c1F)=Nc1c2cccc1)C2=O

InChI

InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H

InChI Key

FABKVBXAAMCULR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01934149

InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H in Drug Discovery

Included in Screening Libraries

Hsp90-Targeted Library (11355 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Carbonic Anhydrase II Library (4939 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H?
Check Price and Availability of InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C22H15FN2O2/c23-19-7-3-1-5-15(19)9-14-21-24-20-8-4-2-6-18(20)22(27)25(21)16-10-12-17(26)13-11-16/h1-14,26H available by request